In Life Sciences, Agilent is helping investigators advance basic research, unlock the genetic causes of disease and accelerate the discovery and development of new drugs. Agilent’s life sciences business addresses the needs of academic, institutional and pharmaceutical scientists in five key areas:
 |
 |
|
|
Genomics researchers require a steady stream of innovative tools to explore the genetic causes of disease. In addition to gene expression studies, Agilent's flexible SurePrint microarray platform powers emerging applications such as aCGH, ChIP-on-chip, microRNA and methylation analysis. |
|
|
 |
Proteomics encompasses the large-scale study of proteins, including protein identification and characterization. Agilent provides complete LC/MS-based solutions from protein isolation through data analysis, as well as protein LabChips for protein quality assessment. |
|
|
 |
Metabolomics, a rapidly emerging field of study, is the comparative analysis of metabolites found in sets of similar biological samples. Agilent offers the industry's most complete range of GC/MS and LC/MS solutions for metabolomic investigation, as well as powerful software tools for metabolite identification, quantitation, and statistical analysis. |
|
|
 |
Bioinformatics enables scientists to bring together disparate sets of biological data to better understand the operation of biological systems. Agilent’s suite of bioinformatics solutions includes the widely-used GeneSpring platform, and spans applications in gene expression, genotyping, aCGH, metabolomics and proteomics. |
|
|
 |
As a market leader in pharmaceutical analysis, Agilent offers products across the entire pharmaceutical value chain, from basic research to drug manufacturing. Focused mainly on drug discovery and drug development, QA/QC and manufacturing, Agilent provides instrumentation, data systems and compliance services designed to meet the requirements of the GMP/GLP-regulated lab. |
|
Products & Services
